Advancements in the treatment of malignancies using a combination of immune checkpoint inhibitors and immunomodulators / 临床外科杂志
Journal of Clinical Surgery
; (12): 92-95, 2024.
Article
in Zh
| WPRIM
| ID: wpr-1019301
Responsible library:
WPRO
ABSTRACT
In recent years,there have been significant advancements in tumor immunotherapy.Immune checkpoint inhibitors have emerged as a pivotal approach for treating advanced malignant tumors.The use of immunotherapy has been widely recommended and applied in clinical treatment both domestically and internationally.However,its clinical treatment efficacy still falls short of expectations.Improving the efficacy of immunotherapy for patients with advanced malignant tumors is currently a prominent research focus.Studies indicate that the combined use of immune enhancers and immune checkpoint inhibitors in various advanced malignant tumors significantly enhances the outcomes of immunotherapy.This article primarily highlights the combined application of immune enhancers and immune checkpoint inhibitors in cancer therapy,offering insights into their potential in the field of oncology treatment.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Clinical Surgery
Year:
2024
Type:
Article